The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Jefferies on September 18, 2024. The analyst firm set a price target for $70.00 expecting EW to rise to within 12 months (a possible 3.86% upside). 64 analyst firms have reported ratings in the last year.

The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Jefferies, and Edwards Lifesciences downgraded their hold rating.

The last upgrade for Edwards Lifesciences Corp happened on July 29, 2024 when Wolfe Research raised their price target to N/A. Wolfe Research previously had an underperform for Edwards Lifesciences Corp.

The last downgrade for Edwards Lifesciences Corp happened on September 18, 2024 when Jefferies changed their price target from $85 to $70 for Edwards Lifesciences Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a downgraded with a price target of $85.00 to $70.00. The current price Edwards Lifesciences (EW) is trading at is $67.40, which is out of the analyst’s predicted range.